The anti-angiogenic activity of NSITC, a specific cathepsin L inhibitor

Keyphrases

• Angiogenesis 100%
• Antiangiogenic Activity 100%
• Cathepsin L 80%
• Chorioallantoic Membrane 60%
• Extracellular Matrix 40%
• Aggressive Tumor 40%
• Matrigel 40%
• Tumor 20%
• In Cancer 20%
• Growth Factors 20%
• Cell Adhesion 20%
• Endothelial Cells 20%
• Vascular Endothelial Growth Factor 20%
• Cell Interaction 20%
• Fibroblast Growth Factor 1 (FGF1) 20%
• Drug Resistance 20%
• G1 Phase 20%
• Cell Cycle Arrest 20%
• Integrin 20%
• Angiogenic Factors 20%
• Tumor Inhibition 20%
• Resistance to Chemotherapy 20%
• Adhesion Molecules 20%
• Endothelial Cell Proliferation 20%
• Potential Drugs 20%

Biochemistry, Genetics and Molecular Biology

• Cathepsin L 100%
• Antiangiogenic Activity 100%
• Angiogenesis 83%
• Growth Factor 16%
• Secretion (Process) 16%
• Cell Adhesion 16%
• Drug Resistance 16%
• Cell Proliferation 16%
• Tumor Progression 16%
• Cell Cycle Arrest 16%
• G1 Phase 16%
• Fibroblast Growth Factor 16%
• Nude Mouse 16%
• Chick 16%
• Vascular Endothelial Growth Factor 16%
• Cell-Cell Interaction 16%
• Cell Cycle Checkpoint 16%
• Cell Adhesion Proteins 16%
• Integrin 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Cathepsin L 100%
• Antiangiogenic 100%
• Malignant Neoplasm 50%
• Matrigel 33%
• Neoplasm 16%
• Tumor Growth 16%
• Growth Factor 16%
• Chemotherapy 16%
• Vasculotropin 16%
• Fibroblast Growth Factor 16%
• Drug Resistance 16%
• Integrin 16%
• Angiogenic Factor 16%
• Nude Mouse 16%
• Chick 16%
• Cell Adhesion Proteins 16%